7
|
|
7
2
pgs
order
Order
Wed 04/02 2:16 PM
STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws)
Related: [-]
|
|
|
utility
Case Assigned/Reassigned
Wed 04/02 11:28 AM
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Related: [-]
|
6
|
|
6
service
Summons Issued
Tue 03/25 2:11 PM
Summons Issued as to Zydus Lifesciences Ltd. on 3/25/2025; Zydus Pharmaceuticals (USA) Inc. on 3/25/2025.(slk)
Related: [-]
|
| |
Att: 1
Summons Issued
|
5
|
|
5
misc
Disclosure Statement - Rule 7.1
Tue 03/25 2:09 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Asahi Kasei Corp. for Calliditas Therapeutics AB filed by Calliditas Therapeutics AB. (slk)
Related: [-]
|
4
|
|
4
misc
Patent/Trademark Report to Commissioner of Patents
Tue 03/25 2:07 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,896,719 B2; 12,171,882 B2; 12,171,883 B2. (slk)
Related: [-]
|
3
|
|
3
misc
ANDA Form
Tue 03/25 2:06 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about February 13, 2025. Date of Expiration of Patent: January 23, 2043. Thirty Month Stay Deadline: 8/13/2027. (slk)
Related: [-]
|
2
|
|
2
misc
Magistrate Consent Forms
Tue 03/25 2:04 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk)
Related: [-]
|
1
|
|
1
16
pgs
cmp
Complaint
Tue 03/25 2:03 PM
COMPLAINT against Zydus Lifesciences Ltd., Zydus Pharmaceuticals (USA) Inc. (Filing fee $ 405, receipt number ADEDC-4645243) - filed by Calliditas Therapeutics AB.(slk)
Related: [-]
|
| |
Att: 1
Exhibit A,
|
| |
Att: 2
Exhibit B,
|
| |
Att: 3
Exhibit C,
|
| |
Att: 4
Exhibit D,
|
| |
Att: 5
Civil Cover Sheet
|